DK0400916T3 - 4,5,6,11-Tetrahydrobenzo(6,7)-cycloocta(1,2-b)-thiophen-6,11-iminer og 6,11-dihydrobenzo(6,7)- cycloocta(1,2-b)thiophen-6,11 iminer - Google Patents
4,5,6,11-Tetrahydrobenzo(6,7)-cycloocta(1,2-b)-thiophen-6,11-iminer og 6,11-dihydrobenzo(6,7)- cycloocta(1,2-b)thiophen-6,11 iminerInfo
- Publication number
- DK0400916T3 DK0400916T3 DK90305716.4T DK90305716T DK0400916T3 DK 0400916 T3 DK0400916 T3 DK 0400916T3 DK 90305716 T DK90305716 T DK 90305716T DK 0400916 T3 DK0400916 T3 DK 0400916T3
- Authority
- DK
- Denmark
- Prior art keywords
- cycloocta
- imines
- thiophene
- compounds
- alkyl
- Prior art date
Links
- 150000002466 imines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 201000006474 Brain Ischemia Diseases 0.000 abstract 1
- 206010008120 Cerebral ischaemia Diseases 0.000 abstract 1
- 208000031124 Dementia Alzheimer type Diseases 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 229940125681 anticonvulsant agent Drugs 0.000 abstract 1
- 239000001961 anticonvulsive agent Substances 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 206010008118 cerebral infarction Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 230000003961 neuronal insult Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Luminescent Compositions (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1989/002387 WO1990015060A1 (en) | 1989-06-01 | 1989-06-01 | 4,5,6,11-TETRAHYDROBENZO[6,7]CYCLOOCTA[1,2-b]THIOPHEN-6,11-IMINES AND 6,11-DIHYDROBENZO[6,7]CYCLOOCTA[1,2-b]THIOPHEN-6,11-IMINES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0400916T3 true DK0400916T3 (da) | 1994-12-05 |
Family
ID=22215050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK90305716.4T DK0400916T3 (da) | 1989-06-01 | 1990-05-25 | 4,5,6,11-Tetrahydrobenzo(6,7)-cycloocta(1,2-b)-thiophen-6,11-iminer og 6,11-dihydrobenzo(6,7)- cycloocta(1,2-b)thiophen-6,11 iminer |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0400916B1 (da) |
| JP (1) | JPH0662630B2 (da) |
| AT (1) | ATE113950T1 (da) |
| CA (1) | CA2017911A1 (da) |
| DE (1) | DE69013983T2 (da) |
| DK (1) | DK0400916T3 (da) |
| ES (1) | ES2063266T3 (da) |
| FI (1) | FI98462C (da) |
| IE (1) | IE64909B1 (da) |
| PT (1) | PT94205B (da) |
| WO (1) | WO1990015060A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5196415A (en) * | 1989-05-09 | 1993-03-23 | The United States Of America As Represented By The Department Of Health And Human Services | 5-aminocarbonyl-5H-dibenzo[a.d]cyclohepten-5,10-imines for treatment of epilepsy and cocaine addiction |
| US5260309A (en) * | 1989-06-01 | 1993-11-09 | Pfizer Inc. | 4,5,6,11-tetrahydrobenzo [6,7] cycloocta [1,2-b]thiophen-6,11-imines and 6,11-dihydrobenzo [6,7] cycloocta [1,2-b] thiophen-6,11-imines |
| GB9002834D0 (en) * | 1990-02-08 | 1990-04-04 | Ici America Inc | Compounds |
| US6413410B1 (en) | 1996-06-19 | 2002-07-02 | Lifescan, Inc. | Electrochemical cell |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3816455A (en) * | 1971-04-23 | 1974-06-11 | Mcneilab Inc | Certain benzothiepino-indoles and indoline-thiochromans |
| US4112110A (en) * | 1974-02-22 | 1978-09-05 | Ciba-Geigy Corporation | Oxygenated azatetracyclic compounds |
| NL7808848A (nl) * | 1977-09-19 | 1979-03-21 | Merck & Co Inc | Dibenzoa.dcyclo-octeen-5.12-(en 6.12)-iminen. |
| US4414154A (en) * | 1977-09-19 | 1983-11-08 | Merck & Co. Inc. | Dibenzo[a,d]cycloocten-5,12-imines |
| US4252810A (en) * | 1978-11-15 | 1981-02-24 | Merck & Co., Inc. | 9,10-Dihydro-4H-benzo[4,5]cyclohepta [1,2-b]thiophen-4,9-imines |
-
1989
- 1989-06-01 WO PCT/US1989/002387 patent/WO1990015060A1/en not_active Ceased
-
1990
- 1990-05-25 DK DK90305716.4T patent/DK0400916T3/da active
- 1990-05-25 DE DE69013983T patent/DE69013983T2/de not_active Expired - Fee Related
- 1990-05-25 EP EP90305716A patent/EP0400916B1/en not_active Expired - Lifetime
- 1990-05-25 ES ES90305716T patent/ES2063266T3/es not_active Expired - Lifetime
- 1990-05-25 AT AT90305716T patent/ATE113950T1/de not_active IP Right Cessation
- 1990-05-30 PT PT94205A patent/PT94205B/pt not_active IP Right Cessation
- 1990-05-30 CA CA002017911A patent/CA2017911A1/en not_active Abandoned
- 1990-05-31 IE IE195190A patent/IE64909B1/en unknown
- 1990-06-01 JP JP2145258A patent/JPH0662630B2/ja not_active Expired - Lifetime
-
1991
- 1991-11-29 FI FI915646A patent/FI98462C/fi active
Also Published As
| Publication number | Publication date |
|---|---|
| WO1990015060A1 (en) | 1990-12-13 |
| ATE113950T1 (de) | 1994-11-15 |
| FI98462C (fi) | 1997-06-25 |
| PT94205B (pt) | 1997-01-31 |
| FI98462B (fi) | 1997-03-14 |
| DE69013983T2 (de) | 1995-03-16 |
| CA2017911A1 (en) | 1990-12-01 |
| DE69013983D1 (de) | 1994-12-15 |
| FI915646A0 (fi) | 1991-11-29 |
| EP0400916A3 (en) | 1991-11-27 |
| JPH0662630B2 (ja) | 1994-08-17 |
| ES2063266T3 (es) | 1995-01-01 |
| IE901951L (en) | 1990-12-01 |
| PT94205A (pt) | 1991-02-08 |
| JPH0320278A (ja) | 1991-01-29 |
| EP0400916B1 (en) | 1994-11-09 |
| IE64909B1 (en) | 1995-09-20 |
| EP0400916A2 (en) | 1990-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2132284T3 (es) | Derivados de carbamato de 2-(piperidin-4-il, piridin-4-il y tetrahidropiridin-4-il)-benzofurano-7, su preparacion y su uso como inhibidores de acetilcolinesterasa. | |
| DE69008142D1 (de) | 4-Substituierten Imidazolen zur Senkung des intraokularen Druckes. | |
| MX13270A (es) | Procedimiento para la preparacion de derivados de 4-aminopiridina | |
| DK213290D0 (da) | Treatment of cerebrovascular disorders | |
| NO905172D0 (no) | Aminokarbonylkarbamater beslektet med fysostigmin og fremgangsmaate for fremstilling derav. | |
| DK0400916T3 (da) | 4,5,6,11-Tetrahydrobenzo(6,7)-cycloocta(1,2-b)-thiophen-6,11-iminer og 6,11-dihydrobenzo(6,7)- cycloocta(1,2-b)thiophen-6,11 iminer | |
| FI900365A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3-fenyyli-5,6-dihydrobents/C/akridiini-7-karboksyylihappojohdannnaisten valmistamiseksi | |
| BR9502079A (pt) | Composto,formulação farmaceutica e processo para preparar um composto | |
| ZA891769B (en) | Heterocyclic compounds | |
| PT87005A (pt) | Process for preparing n-phenethylaminoalkyl-benzamide anti-arrhythmic agents | |
| DK0420224T3 (da) | Anthihepatopatisk middel | |
| ATE283269T1 (de) | 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems | |
| BR9902049A (pt) | Derivados 9a,11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina. | |
| DE68909961D1 (de) | 2-Aminoacetamid Derivate. | |
| IT1274040B (it) | Composizioni farmaceutiche per la prevenzione e/o il trattamento di disturbi gastrointestinali inclusa l'ulcera |